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J3-AMYLOID (1-42) AND ITS ROLE IN DEVELOPING AN ANIMAL 
MODEL OF ALZHEIMER'S DISEASE 
Greg Tinkler, and Dr. Wayne Dornan"', 
Department of Psychology, IWU. 
Alzheimer's disease is a neurodegenerative disorder characterized by 
neurofibrillary tangles and neuritic plaques. The major component of neuritic plaques 
is J3-amyloid. In humans, J3-amyloid is a chain of amino acids varying in length from 
39 to 43. Current studies have shown that J3-amyloid (1-40) is toxic to cells in vitro , 
with the 25-35 chain of amino acids supposedly being responsible for the cell death. 
However, the ability of the protein to cause cell death in vivo is still being questioned. 
One problem is that the (1-40) form has been found to aggregate very rapidly in most 
solvents, which could prevent a successful injection of J3A into a rat. Recently. the 
(1-42) form has been purified and synthesized. As opposed to the (1-40) form, the 
new 42 amino acid sequence has a slower rate of sedimentation, which increases the 
likelihood of an effective injection. In order to determine the effect of J3A (1-42) on 
spatial tasks, 0.5 microliters of the peptide were injected bilaterally into the dorsal 
hippocampus of male Long Evans rats. Control groups were also utilized. The first 
control group consisted of injections of a scrambled version of the peptide, the second 
group being the vehicle (DMSO) alone. The animals, which had been pretrained on a 
radial arm maze, were allowed to recuperate from surgery and were then tested on the 
maze again. The maze consisted of eight arms, five of which were always baited for a 
particular animal. Session latency, latency to first choice, number of correct choices, 
number of reference memory errors, number of correct and incorrect errors, and the 
total number of choices were recorded for each animal. Items that were then 
calculated included the percent of correct choices, the average choice latency, and the 
total number of errors. Testing continued for two weeks, after which the reinforcers 
from three of the arms were removed and shifted them to the three arms which had 
previously been unbaited. Three days later, all reinforcers were removed except for 
the two arms which had been baited for both of the previous configurations. These 
two reconfiguration procedures were done in an attempt to differentiate between 
animals using procedural memory and those relying on declarative memory, which is 
controlled by the hippocampus. The data was analyzed using ANOV A. The rats were 
perfused after testing, and the histologies are currently being completed. There was 
no significant difference between the three groups. These results suggest that 
injections of J3A do not affect the retention of previously learned spatial tasks in the 
rat. Further studies will assess the affects of bilateral injections of J3A (1-42) into the 
hippocampus on the acquisition of a spatial learning task. 
